Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
321.92
-9.07 (-2.74%)
Apr 28, 2026, 4:00 PM EDT - Market closed
PRAX Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for PRAX stock have an average target of 572.13, with a low estimate of 83 and a high estimate of 1,245. The average target predicts an increase of 77.72% from the current stock price of 321.92.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 10 | 9 | 9 | 9 |
| Buy | 2 | 2 | 3 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $510 | Strong Buy | Reiterates | $510 | +58.42% | Apr 14, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $1,245 | Strong Buy | Reiterates | $1,245 | +286.74% | Apr 7, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $843 | Strong Buy | Reiterates | $843 | +161.87% | Apr 6, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $500 | Buy | Initiates | $500 | +55.32% | Feb 24, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $282 → $305 | Hold | Maintains | $282 → $305 | -5.26% | Feb 20, 2026 |
Financial Forecast
Revenue This Year
3.85M
Revenue Next Year
302.15M
from 3.85M
Increased by 7,758.26%
EPS This Year
-15.16
from -13.48
EPS Next Year
-10.70
from -15.16
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 12.7M | 662.8M | ||||||
| Avg | 3.8M | 302.2M | ||||||
| Low | n/a | 95.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 17,139.0% | ||||||
| Avg | - | 7,758.3% | ||||||
| Low | - | 2,374.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -12.29 | -5.27 | ||||||
| Avg | -15.16 | -10.70 | ||||||
| Low | -21.72 | -17.20 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.